Azithromycin

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, azithromycin is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellular infections, toxoplasmosis, and cryptosporidiosis."[1]

Development

Azithromycin was patented in 1982.[2] Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.[3] Non-authorized generic drugs manufactured by Teva, Sandoz, and Abraxis were approved in the United States of America starting in 2005.[3]

Drug toxicity

Drug toxicity includes cardiovascular death.[4]

References

  1. Anonymous (2024), Azithromycin (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. patent:4328334 - Google Patents. Retrieved on 2009-02-01.
  3. 3.0 3.1 Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01. Cite error: Invalid <ref> tag; name "urlDrugs@FDA" defined multiple times with different content
  4. Ray et al. (2012) Azithromycin and the Risk of Cardiovascular Death